Partnership brings the proprietary technology behind Click’s FDA-authorized digital migraine intervention to the Ultrahuman ...

SHANGHAI, April 15, 2024 /PRNewswire/ -- The9 Limited (NCTY) ("The9"), an established Internet company, today announced that its investee WM Therapeutics Co., Ltd. (未名脑脑) ("WM Therapeutics") has ...

BOSTON--(BUSINESS WIRE)--As consumer intrigue and demand for accessible health wearables grows, the convergence of voice artificial intelligence (AI) and proactive health tools is setting the standard ...

Nucleai’s industry-leading solutions for AI-driven spatial analysis and quantitative biomarker scoring will be on display for biopharma companies exploring a biomarker-driven approach for their ADC ...

Ellipsis Health's AI Technology Will Allow Healthcare Providers Using Augmedix to Seamlessly Screen Patients for Symptoms of Anxiety and Depression Augmedix plans to integrate the Ellipsis Health ...

The Bio-Hermes-002 study collects data reflecting the performance of each biomarker in the study, or combination of biomarkers, to assess, diagnose or predict the presence of a variety of pathologies ...

RCE Technologies, Inc. (RCE) is an innovative artificial intelligence (AI) based medical technology company dedicated to early heart attack detection. RCE Technologies Inc. has announced ...

A quantitative screening assay will be developed based on Courtagen’s protein biomarker platform. Courtagen Life Sciences inked a deal with Avaxia Biologics to develop an assay that can streamline the ...